首页 > 最新文献

Bioprocessing最新文献

英文 中文
ICH Q12 Should Build on the ICH Q8 Design Space ICH Q12应建立在ICH Q8设计空间之上
Pub Date : 2018-09-05 DOI: 10.12665/J17OA.WITCHER.0905
Mark Witcher
{"title":"ICH Q12 Should Build on the ICH Q8 Design Space","authors":"Mark Witcher","doi":"10.12665/J17OA.WITCHER.0905","DOIUrl":"https://doi.org/10.12665/J17OA.WITCHER.0905","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42350594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis B Surface Antigen Particle Purification by Immunoaffinity Chromatography Based on CDI-CB.Hep-1 mAb Monolithic Supports 基于CDI-CB.Hep-1mAb整体载体的免疫亲和色谱法纯化乙型肝炎表面抗原颗粒
Pub Date : 2018-06-05 DOI: 10.12665/J17OA.VALDES
R. Valdés, U. Černigoj, Eduardo Sánchez, Daily Hernández, Blass Nemec, M. Limonta, Miguel Castillo, B. Pérez, U. Vidic, J. Vidič, M. Žorž, A. Tamayo, L. Gómez, W. Ferro, Yurisleydi Aldama, N. Krajnc, D. Marc, A. Štrancar
{"title":"Hepatitis B Surface Antigen Particle Purification by Immunoaffinity Chromatography Based on CDI-CB.Hep-1 mAb Monolithic Supports","authors":"R. Valdés, U. Černigoj, Eduardo Sánchez, Daily Hernández, Blass Nemec, M. Limonta, Miguel Castillo, B. Pérez, U. Vidic, J. Vidič, M. Žorž, A. Tamayo, L. Gómez, W. Ferro, Yurisleydi Aldama, N. Krajnc, D. Marc, A. Štrancar","doi":"10.12665/J17OA.VALDES","DOIUrl":"https://doi.org/10.12665/J17OA.VALDES","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45928791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Performance Challenging Fetal Bovine Serum (FBS) and FBS Alternatives 胎牛血清(FBS)及其替代品的性能挑战
Pub Date : 2018-05-21 DOI: 10.12665/j17oa.siegel
W. Siegel
Growth performance testing in cell culture is an effective approach to making serum suitability and purchase decisions.[1] An independent commercial testing lab conducted two separate and sequential growth promotion studies to underscore the need for pre-purchase lot performance testing with: (1) FBS; and (2) FBS alternatives. Results from both studies are presented here to compare and contrast: • FBS lots to each other • FBS alternatives lots to each other • FBS alternatives lots to FBS FBS alternatives are included because they are often overlooked as a cost-effective substitute for FBS, providing, in many cases, equivalent performance. It is advisable to avoid preconceived notions con cern ing the quality or performance of a serum product without considering the culture system, culture con ditions, and the subject cells, which can all have a material impact on its performance in cell culture. Test – then decide. 1. FBS Performance Challenge Test article (TA) lot performance was evaluated with three different cell lines at four TA concentrations. Additionally, the impact of TA concentration used in the cell culture medium was examined. FBS end-users employ various methods for assessing TABLE 1. Test article key, FBS performance challenge. TA # Supplier Description Catalog # Lot # 1 VWR Seradigm FBS 89510-194 013B16 2 VWR Seradigm FBS 89510-194 074B17 3 Testing Lab Control FBS — — 4 VWR Seradigm FB Essence 10805-184 048B16 5 GE Hyclone FBS SH30071.02 AB10104797 6 GE Hyclone FBS SH30071.02 AB10095803 7 ThermoFisher Gibco FBS A3160501 1883391 8 ThermoFisher Gibco FBS A3160501 1876851 the quality of FBS in cell culture. One of the most effective approaches is low-density plating efficiency testing.[1, 2] Plating efficiency is an individual characteristic of each adherent cell line (adhered /plated × 100). At clonal seeding density, the cells are unable to adequately condition the medium and must depend heavily on the nutritional capacity of the culture medium. The experimental design used in these two plating efficiency studies is based upon protocols cited above.[1, 2] 1.1 Materials and Methods Plating efficiency performance testing was conducted by an independent commercial testing lab on randomly selected production lots of FBS from three vendors (VWR Seradigm, GE HyClone, and ThermoFisher Gibco); two lots from each vendor (Table 1). FBS lots were tested in triplicate at four concentrations: 10 %, 7.5 %, 5.0 %, and 2.5 %. The FBS control was the test lab’s in-house lot to which all three cell lines were adapted pre-assay. The FBS control lot was not identical to any of the TA lots. Additionally, one lot of VWR Seradigm FB Essence, an FBS alternative, was included for comparison with this FBS performance challenge. Three adherent-dependent cell types were obtained from ATCC: CCL-34 (MDCK), CCL-75 (WI-38), and CCL-61 (CHO-K1). MDCK and CHO-K1 are cell lines that can be passaged indefinitely. WI-38 is a well-characterized normal human cell with
细胞培养中生长性能测试是制定血清适宜性和购买决策的有效方法一个独立的商业测试实验室进行了两项独立和连续的生长促进研究,以强调购买前批次性能测试的必要性:(1)FBS;(2) FBS替代方案。本文将两项研究的结果进行比较和对比:•FBS批次之间的对比•FBS批次之间的对比•FBS批次之间的对比•FBS批次之间的对比•FBS批次之间的对比•FBS批次之间的对比•FBS批次之间的对比•FBS批次之间的对比FBS批次之所以包括在内,是因为它们作为FBS的成本效益替代品经常被忽视,在许多情况下,它们提供了相同的性能。建议避免对血清产品的质量或性能有先入为主的观念,而不考虑培养系统、培养条件和被试细胞,这些都可能对其在细胞培养中的性能产生实质性影响。测试——然后决定。1. 在四种不同的TA浓度下,用三种不同的细胞系评估FBS性能挑战测试品(TA)批次的性能。此外,研究了细胞培养基中TA浓度的影响。FBS终端用户采用各种方法评估表1。测试文章关键,FBS性能挑战。t#供应商描述目录#批量# 1 VWR Seradigm FBS 89510-194 013B16 2 VWR Seradigm FBS 89510-194 074B17 3测试实验室控制FBS - - 4 VWR Seradigm FB Essence 10805-184 048B16 5 GE Hyclone FBS SH30071.02 AB10104797 6 GE Hyclone FBS SH30071.02 AB10095803 7 ThermoFisher Gibco FBS A3160501 1883391 8 ThermoFisher Gibco FBS A3160501 1876851细胞培养中FBS的质量。其中最有效的方法之一是低密度电镀效率测试。[1,2]镀效率是每个贴壁细胞系的个体特征(贴壁/镀× 100)。在克隆播种密度下,细胞不能充分调节培养基,必须在很大程度上依赖于培养基的营养能力。在这两个电镀效率研究中使用的实验设计是基于上面引用的协议。[1,2]镀层效率性能测试由独立的商业测试实验室随机选择三家供应商(VWR Seradigm、GE HyClone和ThermoFisher Gibco)的FBS生产批次进行;来自每个供应商的两个批次(表1)。FBS批次在四种浓度下进行了三份测试:10%、7.5%、5.0%和2.5%。FBS对照是测试实验室的内部批次,所有三种细胞系在检测前都适用于该批次。FBS的控制批次与TA的任何批次都不相同。此外,还包括了一批VWR Seradigm FB Essence,一种FBS替代品,用于与FBS性能挑战进行比较。ATCC获得三种贴壁依赖性细胞类型:CCL-34 (MDCK), CCL-75 (WI-38)和CCL-61 (CHO-K1)。MDCK和CHO-K1是可以无限传代的细胞系。WI-38是一种具有良好特征的正常人类细胞,其有限寿命约为50倍(不是传代)。这三种细胞系都已用于疫苗生产。每个细胞系的克隆细胞播种水平不同,本研究通过初步测试确定。对每个细胞系检查三个细胞播种水平,以确保生成可用的数据。播种级别为最多的测试文章提供最多的信息
{"title":"Performance Challenging Fetal Bovine Serum (FBS) and FBS Alternatives","authors":"W. Siegel","doi":"10.12665/j17oa.siegel","DOIUrl":"https://doi.org/10.12665/j17oa.siegel","url":null,"abstract":"Growth performance testing in cell culture is an effective approach to making serum suitability and purchase decisions.[1] An independent commercial testing lab conducted two separate and sequential growth promotion studies to underscore the need for pre-purchase lot performance testing with: (1) FBS; and (2) FBS alternatives. Results from both studies are presented here to compare and contrast: • FBS lots to each other • FBS alternatives lots to each other • FBS alternatives lots to FBS FBS alternatives are included because they are often overlooked as a cost-effective substitute for FBS, providing, in many cases, equivalent performance. It is advisable to avoid preconceived notions con cern ing the quality or performance of a serum product without considering the culture system, culture con ditions, and the subject cells, which can all have a material impact on its performance in cell culture. Test – then decide. 1. FBS Performance Challenge Test article (TA) lot performance was evaluated with three different cell lines at four TA concentrations. Additionally, the impact of TA concentration used in the cell culture medium was examined. FBS end-users employ various methods for assessing TABLE 1. Test article key, FBS performance challenge. TA # Supplier Description Catalog # Lot # 1 VWR Seradigm FBS 89510-194 013B16 2 VWR Seradigm FBS 89510-194 074B17 3 Testing Lab Control FBS — — 4 VWR Seradigm FB Essence 10805-184 048B16 5 GE Hyclone FBS SH30071.02 AB10104797 6 GE Hyclone FBS SH30071.02 AB10095803 7 ThermoFisher Gibco FBS A3160501 1883391 8 ThermoFisher Gibco FBS A3160501 1876851 the quality of FBS in cell culture. One of the most effective approaches is low-density plating efficiency testing.[1, 2] Plating efficiency is an individual characteristic of each adherent cell line (adhered /plated × 100). At clonal seeding density, the cells are unable to adequately condition the medium and must depend heavily on the nutritional capacity of the culture medium. The experimental design used in these two plating efficiency studies is based upon protocols cited above.[1, 2] 1.1 Materials and Methods Plating efficiency performance testing was conducted by an independent commercial testing lab on randomly selected production lots of FBS from three vendors (VWR Seradigm, GE HyClone, and ThermoFisher Gibco); two lots from each vendor (Table 1). FBS lots were tested in triplicate at four concentrations: 10 %, 7.5 %, 5.0 %, and 2.5 %. The FBS control was the test lab’s in-house lot to which all three cell lines were adapted pre-assay. The FBS control lot was not identical to any of the TA lots. Additionally, one lot of VWR Seradigm FB Essence, an FBS alternative, was included for comparison with this FBS performance challenge. Three adherent-dependent cell types were obtained from ATCC: CCL-34 (MDCK), CCL-75 (WI-38), and CCL-61 (CHO-K1). MDCK and CHO-K1 are cell lines that can be passaged indefinitely. WI-38 is a well-characterized normal human cell with","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49013938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Development Tools into the Process Validation Lifecycle to Achieve Six Sigma Pharmaceutical Quality 将开发工具集成到过程验证生命周期中以实现六西格玛药品质量
Pub Date : 2018-04-16 DOI: 10.12665/J17OA.WITCHER.0416
Mark Witcher
{"title":"Integrating Development Tools into the Process Validation Lifecycle to Achieve Six Sigma Pharmaceutical Quality","authors":"Mark Witcher","doi":"10.12665/J17OA.WITCHER.0416","DOIUrl":"https://doi.org/10.12665/J17OA.WITCHER.0416","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43827372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Gamma Irradiation of Animal Serum: Maintaining the Cold Chain Throughout the Process 动物血清的伽玛射线照射:全程保持冷链
Pub Date : 2018-01-17 DOI: 10.12665/J17OA.BROWN
Sue A. Brown, B. Croonenborghs, Kevin Head, Mara Senescu, R. Nims, M. Plavsic, R. Versteegen
{"title":"Gamma Irradiation of Animal Serum: Maintaining the Cold Chain Throughout the Process","authors":"Sue A. Brown, B. Croonenborghs, Kevin Head, Mara Senescu, R. Nims, M. Plavsic, R. Versteegen","doi":"10.12665/J17OA.BROWN","DOIUrl":"https://doi.org/10.12665/J17OA.BROWN","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42006520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum 一种区分胎牛血清与新生牛犊血清的方法
Pub Date : 2017-12-22 DOI: 10.12665/J16OA.CHEEVER
M. Cheever, R. Versteegen, A. Master
The continued use of animal serum as an important component in biotechnology manufacturing processes has raised questions regarding both the reliability of geographic origin and possible adulteration of product. The International Serum Industry Association (ISIA) has implemented a traceability certification program designed to demonstrate traceability from slaughterhouse or abattoir to the end-user. This is based on an audit performed by an independent, approved third-party auditor according to an approved audit plan, using a detailed audit checklist. Recent advances have led to the development of a complementary testing program to determine geographic origin of material. The methodology described in this paper differentiates fetal bovine serum from newborn calf serum on the basis of biochemical composition. A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum
动物血清作为生物技术生产过程中的一个重要成分继续使用,这引发了对地理来源可靠性和产品可能掺假的质疑。国际血清工业协会(ISIA)实施了一项可追溯性认证计划,旨在证明从屠宰场或屠宰场到最终用户的可追溯性。这是基于独立的、经批准的第三方审计师根据经批准的审计计划,使用详细的审计清单进行的审计。最近的进展导致了一个补充测试程序的发展,以确定材料的地理来源。本文所述的方法是根据生化成分区分胎牛血清和新生小牛血清。一种区分胎牛血清和新生小牛血清的方法
{"title":"A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum","authors":"M. Cheever, R. Versteegen, A. Master","doi":"10.12665/J16OA.CHEEVER","DOIUrl":"https://doi.org/10.12665/J16OA.CHEEVER","url":null,"abstract":"The continued use of animal serum as an important component in biotechnology manufacturing processes has raised questions regarding both the reliability of geographic origin and possible adulteration of product. The International Serum Industry Association (ISIA) has implemented a traceability certification program designed to demonstrate traceability from slaughterhouse or abattoir to the end-user. This is based on an audit performed by an independent, approved third-party auditor according to an approved audit plan, using a detailed audit checklist. Recent advances have led to the development of a complementary testing program to determine geographic origin of material. The methodology described in this paper differentiates fetal bovine serum from newborn calf serum on the basis of biochemical composition. A Method for Differentiating Fetal Bovine Serum from Newborn Calf Serum","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43725412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Novel Lipid Delivery Mechanism of Cell-Ess Increases Higher Order Glycoforms and the Consistency of Glycan Patterns on Monoclonal Antibodies Produced by CHO Cells Cell-Ess的新型脂质传递机制增加了CHO细胞产生的单克隆抗体的高阶糖型和糖模式的一致性
Pub Date : 2017-10-01 DOI: 10.12665/J16OA.ELHOFY
A. Elhofy, Justin A. Beller
{"title":"Novel Lipid Delivery Mechanism of Cell-Ess Increases Higher Order Glycoforms and the Consistency of Glycan Patterns on Monoclonal Antibodies Produced by CHO Cells","authors":"A. Elhofy, Justin A. Beller","doi":"10.12665/J16OA.ELHOFY","DOIUrl":"https://doi.org/10.12665/J16OA.ELHOFY","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45024595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing and Managing Biopharmaceutical Risks by Building a System Risk Structure (SRS) for Modeling the Flow of Threats Through a Network of Manufacturing Processes 通过建立系统风险结构(SRS)来分析和管理生物制药风险,该结构用于建模制造过程网络中的威胁流
Pub Date : 2017-09-25 DOI: 10.12665/J16OA.WITCHER
Mark Witcher
{"title":"Analyzing and Managing Biopharmaceutical Risks by Building a System Risk Structure (SRS) for Modeling the Flow of Threats Through a Network of Manufacturing Processes","authors":"Mark Witcher","doi":"10.12665/J16OA.WITCHER","DOIUrl":"https://doi.org/10.12665/J16OA.WITCHER","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48935113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pondering Different Scales of Knowledge 对不同知识尺度的思考
Pub Date : 2017-09-21 DOI: 10.12665/J16OA.LUCKOW
V. Luckow
{"title":"Pondering Different Scales of Knowledge","authors":"V. Luckow","doi":"10.12665/J16OA.LUCKOW","DOIUrl":"https://doi.org/10.12665/J16OA.LUCKOW","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42562947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demonstration of Porcine Circovirus Type 2 Inactivation by the Low pH Step of the Trypsin Manufacturing Process Using a New Infectivity Assay 用一种新的感染性测定法通过胰蛋白酶生产过程的低pH步骤证明猪圆环病毒2型灭活
Pub Date : 2017-09-19 DOI: 10.12665/J16OA.REMINGTON
K. Remington, T. Tagmyer
{"title":"Demonstration of Porcine Circovirus Type 2 Inactivation by the Low pH Step of the Trypsin Manufacturing Process Using a New Infectivity Assay","authors":"K. Remington, T. Tagmyer","doi":"10.12665/J16OA.REMINGTON","DOIUrl":"https://doi.org/10.12665/J16OA.REMINGTON","url":null,"abstract":"","PeriodicalId":88836,"journal":{"name":"Bioprocessing","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43774147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bioprocessing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1